With the slowdown in world economic growth, the Hepatitis Test Kits industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Hepatitis Test Kits market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Hepatitis Test Kits market size will be further expanded, we expect that by 2023, The market size of the Hepatitis Test Kits will reach XXX million $.
Approval and launch of new products is expected to propel growth of the global hepatitis test kits market over the forecast period. For instance, in April 2020, F. Hoffmann-La Roche AG received the U.S. Food and Drug Administration approval for its cobas HPV test for use on the fully automated, high-throughput cobas 6800/8800 Systems. Moreover, increasing prevalence of hepatitis is also expected to aid in growth of the market. For instance, according to the study, ‘Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda’, published in May 2019, in BMC Infectious Diseases, the prevalence of hepatitis B surface antigen was 3.9% in the study population.
R&D in biochips is expected to offer lucrative growth opportunities for players in the global hepatitis test kits market. For instance, in May 2020, researchers from Russian Academy of Sciences, Russia, reported development of 3D biochips and optimized analytical procedures that can facilitate further studies towards practical application for hepatitis C virus detection. Moreover, increasing awareness regarding hepatitis is also expected to aid in growth of the market. For instance, in May 2020, Echosens, a provider of non-invasive diagnostic products and services for liver diagnosis, urged increased vigilance around liver health during May 2020 Hepatitis Awareness Month.
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a developer of instruments and consumables for the isolation, detection, and analysis of single cells.
Major players in the market are also focused on approval and launch of new products to expand their product portfolio. For instance, in February 2019, Abbott Laboratories received CE Mark for Determine HBsAg 2 test, a rapid diagnostic test for the detection of hepatitis B surface antigen.
Key Takeaways
Increasing prevalence of hepatitis to augment growth of the global hepatitis test kits market over the forecast period
Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in January 2020, LabCorp, along with its subsidiary Covance Inc., partnered with GENFIT, a biopharmaceutical company focused on R&D in liver diseases, for access to non-alcoholic steatohepatitis liver diagnostic test for the clinical research market.
Major players operating in the global hepatitis test kits market include, F. Hoffmann-La Roche AG, Siemens Healthineers, Abbott Laboratories, Bio-Rad Laboratories, BioMerieux, Qiagen, Meridian Bioscience, Hologic, Covance Inc., and Creative Diagnostics.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
Roche
Siemens
Abbott Laboratories
Bio-Rad Laboratories
BioMerieux
Qiagen
Meridian Bioscience
Hologic
Creative Diagnostics
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Hepatitis B Test Kit
Hepatitis C Test Kit
Industry Segmentation
Hospitals
Clinics
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2018-2023)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
